Rothschild & Co Asset Management US’s ResMed RMD Stock Holding History

Rothschild & Co Asset Management US’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,435	Closed	-$391K	–	579
2017 Q1	$391K	Sell	5,435 -2,736	-33%	-$189K	﹤0.01%	560
2016 Q4	$507K	Buy	8,171 +332	+4%	+$20.3K	0.01%	523
2016 Q3	$508K	Sell	7,839 -375	-5%	-$25K	0.01%	440
2016 Q2	$519K	Sell	8,214 -589	-7%	-$34.7K	0.01%	391
2016 Q1	$509K	Buy	8,803 +2,679	+44%	+$152K	0.01%	332
2015 Q4	$329K	Buy	+6,124	New	+$345K	0.01%	359

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rothschild & Co Asset Management US's RMD Position: Q2 2017 in Review

Rothschild & Co Asset Management US sold out of ResMed (RMD) in Q2 2017, closing a stake of 5,435 shares — an estimated $391K sold.

Rothschild & Co Asset Management US first reported a position in RMD in Q4 2015 and held it in 6 quarters. The position peaked at $519K in Q2 2016. 339 funds tracked by Wall St. Rank hold RMD as of Q2 2017.

Rothschild & Co Asset Management US reported no remaining ResMed position as of Q2 2017 after selling out during the quarter.
Rothschild & Co Asset Management US sold 5,435 ResMed shares in Q2 2017, an estimated $391K.
Rothschild & Co Asset Management US first reported a position in ResMed in Q4 2015 and held it in 6 quarters.
Rothschild & Co Asset Management US's ResMed position peaked at $519K in Q2 2016.
339 funds tracked by Wall St. Rank held ResMed as of Q2 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2017, filed 27 Jul 2017.